Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats

European Journal of Pharmacology

Volumn 544, Issue 1-3, 2006, Pages 181-187

  Adachi, Naoto ^a,b   Liu, Keyue ^a,b   Motoki, Atsuko ^a,b   Nishibori, Masahiro ^a,b   Arai, Tatsuru ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

(Rat); Histamine; Histamine H4 receptor; Liver ischemia; Portal vein

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CIMETIDINE; CLOZAPINE; DIMAPRIT; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; MEPYRAMINE; THIOPERAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; LIVER INJURY; LIVER ISCHEMIA; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CLOZAPINE; DIMAPRIT; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; ISCHEMIA; LIVER; MALE; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; REPERFUSION INJURY; TIME FACTORS;

EID: 33746590646     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.053     Document Type: Article

References (23)

1. Adachi N., Ochi T., Tabo E., Nagaro T., and Arai T. Prostaglandin E1 improves hepatic encephalopathy produced by ischaemia-reperfusion liver injury in rats. Intensive Care Med. 26 (2000) 1681-1684
2. Dy M., and Schneider E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev. 15 (2004) 393-410
3. Elenkov I.J., Webster E., Papanicolaou D.A., Fleisher T.A., Chrousos G.P., and Wilder R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161 (1998) 2586-2593
4. 4 receptor antagonists: the new antihistamines?. Curr. Opin. Investig. Drugs 5 (2004) 1174-1183
5. Gutzmer R., Diestel C., Mommert S., Köther B., Stark H., Wittmann M., and Werfel T. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J. Immunol. 174 (2005) 5224-5232
6. Hilkens C.M., Kalinski P., de Boer M., and Kapsenberg M.L. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90 (1997) 1920-1926
7. Hirasawa N., Ohuchi K., Watanabe M., and Tsurufuji S. Role of endogenous histamine in postanaphylactic phase of allergic inflammation in rats. J. Pharmacol. Exp. Ther. 241 (1987) 967-973
8. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003) 1212-1221
9. Hornyak S.C., Gehlsen K.R., and Haaparanta T. Histamine dihydrochloride protects against early alcohol-induced liver injury in a rat model. Inflammation 27 (2003) 317-327
10. Kawano K., Kim Y.I., Kaketani K., and Kobayashi M. The beneficial effect of cyclosporine on liver ischemia in rats. Transplantation 48 (1989) 759-764
11. 4 receptor agonist. J. Pharmacol. Exp. Ther. 314 (2005) 1310-1321
12. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 142 (2004) 161-171
13. 4) expressed in bone marrow. Mol. Pharmacol. 59 (2001) 420-426
14. Morse K.L., Behan J., Laz T.M., West Jr. R.E., Greenfeder S.A., Anthes J.C., Umland S., Wan Y., Hipkin R.W., Gonsiorek W., Shin N., Gustafson E.L., Qiao X., Wang S., Hedrick J.A., Greene J., Bayne M., and Monsma Jr. F.J. Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. 296 (2001) 1058-1066
15. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17 (1996) 138-146
16. Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., Rauser L., Lee S.P., Lynch K.R., Roth B.L., and O'Dowd B.F. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 59 (2001) 427-433
17. Oda T., Morikawa N., Saito Y., Masuho Y., and Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275 (2000) 36781-36786
18. Okajima K., Harada N., and Uchiba M. Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation. J. Pharmacol. Exp. Ther. 301 (2002) 1157-1165
19. Packard K.A., and Khan M.M. Effects of histamine on Th1/Th2 cytokine balance. Int. Immunopharmacol. 3 (2003) 909-920
20. Sakr M.F., Hassanein T.I., Zetti G.M., and Van Thiel D.H. FK 506 ameliorates the hepatic injury associated with ischemia. Life Sci. 47 (1990) 687-691
21. 4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309 (2004) 404-413
22. Yokoyama M., Yokoyama A., Mori S., Takahashi H.K., Yoshino T., Watanabe T., Watanabe T., Ohtsu H., and Nishibori M. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 127 (2004) 892-902
23. Zhu Y., Michalovich D., Wu H., Tan K.B., Dytko G.M., Mannan I.J., Boyce R., Alston J., Tierney L.A., Li X., Herrity N.C., Vawter L., Sarau H.M., Ames R.S., Davenport C.M., Hieble J.P., Wilson S., Bergsma D.J., and Fitzgerald L.R. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 59 (2001) 434-441